Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 7, 2005, Pages 725-732

  Zhang, Ying Tao ^a   Geng, Yi Ping ^a   Si, Lu Sheng ^a   Wang, Yi Li ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Mass spectrometry; Metastasis; Two dimensional gel electrophoresis

Indexed keywords

APOLIPOPROTEIN B48; BINDING PROTEIN; CARBOXYPEPTIDASE A; CYCLIN DEPENDENT KINASE 1; DNA DIRECTED RNA POLYMERASE; ENDOTHELIAL CELL GROWTH FACTOR; IMMUNOGLOBULIN; INTEGRIN; ISOPROTEIN; LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; SEPTIN; SIALIC ACID; TRANSCRIPTION FACTOR; TYROSINASE RELATED PROTEIN 2; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MOTILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN CELL; LECTIN BINDING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TUMOR IMMUNITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADENOCARCINOMA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 21244496772     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200507000-00006     Document Type: Article

References (45)

1. Trainer DL, Kline T, McCabe FL, Faucette LF, Feild J, Chaikin M, et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 1988; 41:287-296.
2. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995; 64:79-82.
3. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995; 55:510-513.
4. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, et al. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994; 86:1234-1238.
5. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73:884-888.
6. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, et al. The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 1996; 32A:1 227-1232.
7. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells [see Comments]. J Natl Cancer Inst 1996; 88:1146-1151.
8. Takeda A, Stoeltzing O, Ahmad SA, Reinmuth N, Liu W, Parikh A, et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol 2002; 9:610-616.
9. Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori M. Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility. Ann Surg Oncol 2003; 10:582-587.
10. Konno S, Takebayashi Y, Higashimoto M, Katsube T, Kanzaki A, Kawahara M, et al. Thymidine phosphorylase expression in gastric carcinoma as a marker for metastasis. Anticancer Res 2003; 23:5011-5014.
11. Saito S, Tsuno N, Nagawa H, Sunami E, Zhengxi J, Osada T, et al. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma. Cancer 2000; 88:42-49.
12. Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene 2004; 23:8731-8742.
13. Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY. Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma. J Biomed Sci 2004; 11:661-670.
14. Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004; 204:489-505.
15. Taki T, Ohnishi H, Shinohara K, Sako M, Bessho F, Yanagisawa M, Itayashi Y. AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17) (q23;q25). Cancer Res 1999; 59: 4261-4265.
16. Tanaka M, Kijima H, Itoh J, Matsuda T, Tanaka T. Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo. Cancer Gene Ther 2002; 9:483-488.
17. Tanaka M, Tanaka T, Matsuzaki S, Seto Y, Matsuda T, Komori K, et al. Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers. Med Sci Monit 2003; 9:61-68.
18. Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, et al. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003; 63:2179-2187.
19. Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, et al. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 2003; 201:581-588.
20. Kim DS, Hubbard SL, Peraud A, Salhia B, Sakai K, Rutka JT. Analysis of mammalian septin expression in human malignant brain tumors. Neoplasia 2004; 6:168-178.
21. Koshelev YA, Kiselev SL, Georgiev GP. Interaction of the S100A4 (Mts1) protein with septins Sept2, Sept6, and Sept7 in vitro. Dokl Biochem Biophys 2003; 391:195-197.
22. Pawlack G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Cell Biol 2001; 11:41-47.
23. Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 1988; 54:17-26.
24. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-440.
25. Wada S, Yue L, Furuta I. Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma. Oral Oncol 2004; 40:164-169.
26. Nozoe T, Honda M, Inutsuka S, Korenaga D. p34cdc2 Expression is an independent indicator for lymph node metastasis in colorectal carcinoma. J Cancer Res Clin Oncol 2003; 12:498-502.
27. Crocket PR, Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol 2001; 22:337-342.
28. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296:298-300.
29. Vely F, Vivier E. Commentary: conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol 1997; 159:2075-2077.
30. Altevogt P, Fogel M, Cheingsong-Popov R, Dennis J, Robinson P, Schirrmacher V. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res 1983; 43:5138-5144.
31. Kumar AS, Naruszewicz I, Wang P, Leung-Hagesteijn C, Hannigan GE. ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 2004; 23:3454-3461.
32. Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005; 5:51-63.
33. Marotta A, Parhar K, Owen D, Dedhar S, Salh B. Characterization of integrin-linked kinase signaling in sporadic human colon cancer. Br J Cancer 2003; 88:1755-1762.
34. Persad S, Dedhar S. The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 2003; 22:375-384.
35. Redondo M, Garcia J, Villar E, Rodrigo I, Perea-Milla E, Serrano A, et al. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis. Hum Pathol 2003; 34:1283-1289.
36. Bernsen MR, Hakansson L, Gustafsson B, Krysander L, Rettrup B, Ruiter D, et al. On the biological relevance of MHC class II and B7 expression by tumor cells in melanoma metastases. Br J Cancer 2003; 88:424-431.
37. Brem R, Hildebrandt T, Jarsch M, Van Muijen GN, Weidle UH. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line. Anticancer Res 2001; 21:1731-1740.
38. Janssens V, Gorisi J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 2001; 353:417-439.
39. Fellner T, Lackner DH, Hombauer H, Piribauer P, Mudrak I, Zaragoza K, et al. A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo. Genes Dev 2003; 17:2138-2150.
40. Huang H, Reed CP, Zhang JS, Shridhar V, Wang L, Smith DI. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res 1999; 59:2981-2988.
41. Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 1996; 13:447-453.
42. Okamoto Y. Other apolipoproteins (apolipoprotein F, G, H, J, L, M, SAA and so on). Nippon Rinsho 2001; 59:141-144.
43. Vogel T, Guo NH, Guy R, Drezlich N, Krutzsch HC, Blake DA, et al. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 1994; 54:299-308.
44. Yu HK, Ahn JH, Lee HJ, Lee SK, Hong SW, Yoon Y, et al. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. J Gene Med 2005; 7:39-49.
45. Yu HK, Kim JS, Lee HJ, Ahn JH, Lee SK, Hong SW, et al. Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles. Cancer Res 2004; 64:7092-7098.